Cargando…

Comprehensive analysis of blood-based biomarkers for predicting immunotherapy benefits in patients with advanced non-small cell lung cancer

BACKGROUND: This study aimed to investigate the feasibility of using circulating tumor cells (CTCs), peripheral blood cells (PBCs), and circulating cell-free DNA (cfDNA) as biomarkers of immune checkpoint inhibitor treatment response in patients with advanced non-small cell lung cancer (NSCLC). METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Cheol-Kyu, Oh, Hyung-Joo, Kim, Min-Seok, Koh, Bo-Gun, Cho, Hyun-Ju, Kim, Young-Chul, Yang, Hyung-Jeong, Lee, Ji-Young, Chun, Sung-Min, Oh, In-Jae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182702/ https://www.ncbi.nlm.nih.gov/pubmed/34164263 http://dx.doi.org/10.21037/tlcr-21-100

Ejemplares similares

Potentially fatal complications of systemic air embolism after computed tomography‐guided transthoracic needle biopsy in lung cancer harboring epithelial growth factor receptor mutation: A case report
por: Oh, Hyung‐Joo, et al.
Publicado: (2020)

Efficacy and dose of afatinib in patients with non‐small cell lung cancer after failure of prior gefitinib or erlotinib treatment
por: Choi, Hayoung, et al.
Publicado: (2021)

Blood-Based Biomarker Analysis for Predicting Efficacy of Chemoradiotherapy and Durvalumab in Patients with Unresectable Stage III Non-Small Cell Lung Cancer
por: Park, Cheol-Kyu, et al.
Publicado: (2023)

Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial
por: Park, Cheol-Kyu, et al.
Publicado: (2023)

Clinical Validation of a Protein Biomarker Panel for Non-Small Cell Lung Cancer
por: Jung, Young Ju, et al.
Publicado: (2018)

Glutathione Peroxidase 3 as a Biomarker of Recurrence after Lung Cancer Surgery
por: Kho, Bo Gun, et al.
Publicado: (2020)

Surgical Strategies and Perioperative Considerations for Cervical Deformity With Cerebral Palsy: A Comprehensive Review of the Literature
por: Kim, Hyung Cheol, et al.
Publicado: (2022)

Serum KL-6 levels predict the occurrence and severity of treatment-related interstitial lung disease in lung cancer
por: Park, Hwa Kyung, et al.
Publicado: (2023)

Risk factors for cerebral complications in patients with pulmonary arteriovenous malformations: A multicenter retrospective cohort study
por: Na, Young-Ok, et al.
Publicado: (2022)

Predicting Tumor Budding Status in Cervical Cancer Using MRI Radiomics: Linking Imaging Biomarkers to Histologic Characteristics
por: Chong, Gun Oh, et al.
Publicado: (2021)

A Propensity-Matched Retrospective Comparative Study with Historical Control to Determine the Real-World Effectiveness of Durvalumab after Concurrent Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer
por: Park, Cheol-Kyu, et al.
Publicado: (2023)

Feasibility of liquid biopsy using plasma and platelets for detection of anaplastic lymphoma kinase rearrangements in non-small cell lung cancer
por: Park, Cheol-Kyu, et al.
Publicado: (2019)

Benefits of stereotactic ablative radiotherapy combined with incomplete transcatheter arterial chemoembolization in hepatocellular carcinoma
por: Paik, Eun Kyung, et al.
Publicado: (2016)

Mapping patterns of para-aortic lymph node recurrence in cervical cancer: a retrospective cohort analysis
por: Bae, Bong Kyung, et al.
Publicado: (2021)

High Physical Self-Concept Benefits on School Adjustment of Korean Student-Athletes
por: Kim, Young-Jae, et al.
Publicado: (2020)

Functional Benefit after Modification of Radial Forearm Free Flap for Soft Palate Reconstruction
por: Kim, Jin-Hwan, et al.
Publicado: (2008)

Novel biomarkers for the diagnosis and prognosis of colorectal cancer
por: Oh, Hyung-Hoon, et al.
Publicado: (2020)

Delayed diagnosis of lung cancer due to misdiagnosis as worsening of sarcoidosis: a case report
por: Shin, Hong-Joon, et al.
Publicado: (2020)

Co-alteration of EGFR mutation and ALK rearrangement in non-small cell lung cancer: Case series
por: Shin, Hong-Joon, et al.
Publicado: (2019)

Optical Coherence Tomographic Finding in a Case of Macular Coloboma
por: Oh, Joo Youn, et al.
Publicado: (2007)

Collaborative Care to Relieve Psychological Distress in Patients with Medically Inoperable Lung Cancer: Design and Rationale for a Clinical Trial
por: Kim, Seon-Young, et al.
Publicado: (2019)

Clinical characteristics and prognosis of patients with Pneumocystis jirovecii pneumonia without a compromised illness
por: Kim, Tae-Ok, et al.
Publicado: (2021)

Evaluation of endothelial cell-specific molecule-1 as a biomarker of glycocalyx damage in canine myxomatous mitral valve disease
por: Hong, Hee-Jeong, et al.
Publicado: (2022)

A Phase II Trial of Osimertinib in the Second-Line Treatment of Non-small Cell Lung Cancer with the EGFR T790M Mutation, Detected from Circulating Tumor DNA: LiquidLung-O-Cohort 2
por: Park, Cheol-Kyu, et al.
Publicado: (2019)

A Phase II Trial of Osimertinib as the First-Line Treatment of Non–Small Cell Lung Cancer Harboring Activating EGFR Mutations in Circulating Tumor DNA: LiquidLung-O-Cohort 1
por: Park, Cheol-Kyu, et al.
Publicado: (2021)

A Case of Gastritis Associated with Gastric Capillariasis
por: Kim, Jin, et al.
Publicado: (2009)

Clinical Implications for the Comprehensive Interpretation of Radiologic and Immunodiagnostic Tests in Patients Suspected of Parasitic Hepatic Cyst, a Rare Case in Korea
por: Yoo, Jae-Sung, et al.
Publicado: (2023)

What is Currently the Best for Adenocarcinoma without Driver Mutation?
por: Park, Cheol-Kyu, et al.
Publicado: (2018)

Superior vena cava syndrome with extensive collateral vessels
por: Oh, In‐Jae, et al.
Publicado: (2019)

Is transformed small cell lung cancer (SCLC) different from de novo SCLC?
por: Park, Cheol-Kyu, et al.
Publicado: (2019)

Role of adjuvant treatment in stage IB non-small cell lung carcinoma
por: Park, Cheol-Kyu, et al.
Publicado: (2023)

Open-label, multi-center, phase II study of adjuvant pemetrexed plus cisplatin for completely resected stage IB to IIIA adenocarcinoma of the lung: APICAL trial
por: Park, Cheol-Kyu, et al.
Publicado: (2022)

Hypersensitivity reactions to multiple anti-tuberculosis drugs
por: Shin, Hong-Joon, et al.
Publicado: (2021)

Quantification of epidermal growth factor receptor (EGFR) mutation may be a predictor of EGFR‐tyrosine kinase inhibitor treatment response
por: Park, Ha Young, et al.
Publicado: (2016)

Erratum to: Proangiogenic TIE2(+)/CD31(+) Macrophages Are the Predominant Population of Tumor-Associated Macrophages Infiltrating Metastatic Lymph Nodes
por: Kim, Ok-Hee, et al.
Publicado: (2014)

Effects of probiotics or broccoli supplementation on Helicobacter pylori eradication with standard clarithromycin-based triple therapy
por: Chang, Young Woon, et al.
Publicado: (2020)

Oncologic Benefits of Neoadjuvant Treatment versus Upfront Surgery in Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: Jung, Hye-Sol, et al.
Publicado: (2022)

Efficacy of immune checkpoint inhibitors according to PD‐L1 tumor proportion scores in non‐small cell lung cancer
por: Park, Seongho, et al.
Publicado: (2019)

Efficacy and Safety of Sugammadex for the Reversal of Rocuronium-Induced Neuromuscular Blockade in Patients with End-Stage Renal Disease: A Systematic Review and Meta-Analysis
por: Kim, Young-Sung, et al.
Publicado: (2021)

A Disintegrin and Metalloproteinase 9 (ADAM9) in Advanced Hepatocellular Carcinoma and Their Role as a Biomarker During Hepatocellular Carcinoma Immunotherapy
por: Oh, Sooyeon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2svc3c48ipccoaq1ipmf9f762n